Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Myeloid 3Lymphoid 3Plasma cell 2Other hematologic neoplasm 2Classical hematology 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 55Leukemia, Myeloid, Acute 44Myelodysplastic Syndromes 39Lymphoma, Non-Hodgkin 34Lymphoma 32Leukemia 31Leukemia, Myelogenous, Chronic, BCR-ABL Positive 22Hodgkin Disease 19Leukemia, Lymphocytic, Chronic, B-Cell 17Burkitt Lymphoma 15Multiple Myeloma 12Lymphoma, Large B-Cell, Diffuse 12Leukemia, Biphenotypic, Acute 12Leukemia, Myeloid, Accelerated Phase 11Lymphoma, Large-Cell, Immunoblastic 10Lymphoma, Follicular 10Hematologic Neoplasms 10Dendritic Cell Sarcoma, Interdigitating 10Blast Crisis 10Lymphoma, Mantle-Cell 9Myeloproliferative Disorders 8Lymphoma, B-Cell, Marginal Zone 8Leukemia, Myeloid, Chronic-Phase 8Graft vs Host Disease 8Anemia, Refractory, with Excess of Blasts 8Leukemia, Myelomonocytic, Juvenile 7Congenital Abnormalities 7Recurrence 6Lymphoma, Large-Cell, Anaplastic 6Waldenstrom Macroglobulinemia 5

Interventions

Brentuximab Vedotin 21Cyclophosphamide 17Rituximab 11fludarabine 9Mycophenolic Acid 9pirtobrutinib 7dacetuzumab 7Busulfan 7fludarabine phosphate 6Tacrolimus 6Melphalan 6Whole-Body Irradiation 5Doxorubicin 5Vincristine 4Prednisone 4Mesna 4Etoposide 4Bone Marrow Transplantation 4Bendamustine Hydrochloride 4ibrutinib 3Thiotepa 3Sirolimus 3Cyclosporine 3Bortezomib 3ponatinib 2Vorinostat 2Stem Cell Transplantation 2Rifampin 2Platelet Transfusion 2Peripheral Blood Stem Cell Transplantation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Hematologic Diseases × Thiotepa × Lymphoid × Clear all
NCT04282174 2022-09-27

2019-KOE-001

Baptist Health South Florida

Phase 2 Withdrawn
LymphoidMyeloidOther hematologic neoplasm

Hematologic Diseases, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02660281 2021-11-03

HaploOnly

University of Rochester

Phase 1 Completed
74 enrolled
LymphoidMyeloidPlasma cell

Hematologic Diseases, Lymphoma, Multiple Myeloma, Primary Myelofibrosis

NCT01010217 2020-03-25

Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide

M.D. Anderson Cancer Center

Phase 2 Completed
176 enrolled 18 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Hematologic Diseases, Hodgkin Disease, Leukemia, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡